IL109470A0 - Water soluble camptothecin derivatives, their preparation and pharmaceutical compositions containing them - Google Patents

Water soluble camptothecin derivatives, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL109470A0
IL109470A0 IL10947094A IL10947094A IL109470A0 IL 109470 A0 IL109470 A0 IL 109470A0 IL 10947094 A IL10947094 A IL 10947094A IL 10947094 A IL10947094 A IL 10947094A IL 109470 A0 IL109470 A0 IL 109470A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
water soluble
compositions containing
camptothecin derivatives
Prior art date
Application number
IL10947094A
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of IL109470A0 publication Critical patent/IL109470A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10947094A 1993-04-29 1994-04-28 Water soluble camptothecin derivatives, their preparation and pharmaceutical compositions containing them IL109470A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5458593A 1993-04-29 1993-04-29
US8104293A 1993-06-22 1993-06-22

Publications (1)

Publication Number Publication Date
IL109470A0 true IL109470A0 (en) 1994-07-31

Family

ID=26733234

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10947094A IL109470A0 (en) 1993-04-29 1994-04-28 Water soluble camptothecin derivatives, their preparation and pharmaceutical compositions containing them

Country Status (10)

Country Link
EP (1) EP0696285A1 (en)
JP (1) JPH08509740A (en)
AP (1) AP9400638A0 (en)
AU (1) AU6777194A (en)
CA (1) CA2161681A1 (en)
IL (1) IL109470A0 (en)
IS (1) IS4152A (en)
MY (1) MY141374A (en)
PE (1) PE52894A1 (en)
WO (1) WO1994025466A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6504029B1 (en) * 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
US5663177A (en) * 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
SG104284A1 (en) 1996-10-30 2004-06-21 Tanabe Seiyaku Co S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
US6559309B2 (en) 1996-11-01 2003-05-06 Osi Pharmaceuticals, Inc. Preparation of a camptothecin derivative by intramolecular cyclisation
US6046209A (en) * 1997-05-27 2000-04-04 Smithkline Beecham Corporation Water soluble camptothecin analogs
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165346T3 (en) * 1989-09-15 2002-03-16 Res Triangle Inst ANALOGS OF 10,11-METHYLENDIOXI-20 (RS) -CAMPTOTECINE AND 10.11-METHYLENDIOXI-20 (S) -CAMPTOTECINE.
DK0540099T3 (en) * 1991-10-29 1996-06-17 Glaxo Wellcome Inc Water-soluble camptothecin derivatives
EP0556585A3 (en) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents

Also Published As

Publication number Publication date
MY141374A (en) 2010-04-16
EP0696285A1 (en) 1996-02-14
PE52894A1 (en) 1995-01-06
AP9400638A0 (en) 1995-10-28
IS4152A (en) 1994-10-30
JPH08509740A (en) 1996-10-15
WO1994025466A1 (en) 1994-11-10
CA2161681A1 (en) 1994-11-10
AU6777194A (en) 1994-11-21

Similar Documents

Publication Publication Date Title
IL103571A0 (en) Water soluble camptothecin derivatives,their preparation and pharmaceutical compositions containing them
IL99225A0 (en) 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them
IL112384A0 (en) Tetracyclic derivatives, their preparation and pharmaceutical compositions containing them
IL111314A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL108729A0 (en) Pyrrolo-pyridine derivatives, their preparation and pharmaceutical compositions containing them
IL101864A0 (en) Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL91129A0 (en) Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them
IL90245A0 (en) Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them
IL100262A0 (en) Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them
IL95045A0 (en) Thienodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL109234A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL97050A0 (en) 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation
IL108859A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL94082A0 (en) 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them
NZ230868A (en) Dihydroartemisinin derivatives, preparation and pharmaceutical compositions thereof
IL98542A0 (en) Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
IL118410A0 (en) Substituted camptothecin derivatives their preparation and pharmaceutical compositions containing them
IL110980A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL111294A0 (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
IL112097A0 (en) Indoline derivatives, their preparation and pharmaceutical compositions containing them
IL108636A0 (en) Polysubstitued 2-amino-thiazole derivatives, their preparation and pharmaceutical compositions containing them
IL108703A0 (en) Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them
IL93124A0 (en) Benzocycloalkenyldihydroxyalkanoic-acid derivatives,their preparation and pharmaceutical compositions
IL103020A0 (en) Imidazopyridine derivatives,their preparation and pharmaceutical compositions containing them
IL92710A0 (en) 2-iminobenzothiazoline derivatives,their preparation and pharmaceutical compositions containing them